Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins

2010 ◽  
Vol 41 (1) ◽  
pp. 26-32 ◽  
Author(s):  
Agnieszka K. Witkiewicz ◽  
Thomas McConnell ◽  
Magdalena Potoczek ◽  
Robert V.B. Emmons ◽  
Robert J. Kurman
2006 ◽  
Vol 214 (1) ◽  
pp. 229-238 ◽  
Author(s):  
Francois Ghiringhelli ◽  
Cédric Ménard ◽  
Francois Martin ◽  
Laurence Zitvogel

2011 ◽  
Vol 6 (3) ◽  
pp. 432-438 ◽  
Author(s):  
Thomas Schneider ◽  
Silvia Kimpfler ◽  
Arne Warth ◽  
Philipp A. Schnabel ◽  
Hendrik Dienemann ◽  
...  

Author(s):  
Runze Qiu ◽  
Yue Zhong ◽  
Qingquan Li ◽  
Yingbin Li ◽  
Hongwei Fan

During metabolic reprogramming, glioma cells and their initiating cells efficiently utilized carbohydrates, lipids and amino acids in the hypoxic lesions, which not only ensured sufficient energy for rapid growth and improved the migration to normal brain tissues, but also altered the role of immune cells in tumor microenvironment. Glioma cells secreted interferential metabolites or depriving nutrients to injure the tumor recognition, phagocytosis and lysis of glioma-associated microglia/macrophages (GAMs), cytotoxic T lymphocytes, natural killer cells and dendritic cells, promoted the expansion and infiltration of immunosuppressive regulatory T cells and myeloid-derived suppressor cells, and conferred immune silencing phenotypes on GAMs and dendritic cells. The overexpressed metabolic enzymes also increased the secretion of chemokines to attract neutrophils, regulatory T cells, GAMs, and dendritic cells, while weakening the recruitment of cytotoxic T lymphocytes and natural killer cells, which activated anti-inflammatory and tolerant mechanisms and hindered anti-tumor responses. Therefore, brain-targeted metabolic therapy may improve glioma immunity. This review will clarify the metabolic properties of glioma cells and their interactions with tumor microenvironment immunity, and discuss the application strategies of metabolic therapy in glioma immune silence and escape.


2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Wanwisa Waiyaput ◽  
Keerati Wattanakamolchai ◽  
Yada Tingthanatikul ◽  
Srithean Lertvikool ◽  
Siriluk Tantanavipas ◽  
...  

Abstract Background Dysregulation of immune response is associated with development of endometriosis. The study aim was to evaluate effect of combined oral contraceptive pills (COCs) consisting of ethinyl estradiol (EE) and desogestrel on the expression of macrophage, natural killer cells, and regulatory T cells of ovarian endometriotic cysts. Methods Endometriotic cyst wall tissues were collected from women with endometriosis who were treated (n = 22) with COCs (one table per day of EE 0.03 mg and desogestrel 0.15 mg administered for 28 to 35 days before surgery) or untreated (n = 22). The tissues were collected from endometriotic cyst wall during laparoscopic or laparotomy ovarian cystectomy. Immunohistochemistry for anti-CD68, anti-CD56, and anti-forkhead–winged helix transcription factor (FoxP3), a marker for macrophages, natural killer cells, and regulatory T cells, respectively, were investigated. Results The median (interquartile range [IQR]) number of anti-CD68 positive cells in the COC group was significantly lower than in the untreated group (12.7; 4.9–19.3) versus 45.7 (26.0–70.7), p < 0.001). Tissue infiltration of anti-CD56 positive cells in endometriotic cyst was significantly higher after the treatment when compared with tissue from untreated group (42.9, 27.4–68.9 versus 25.3 (14.1–37.3; p = 0.009). The number of regulatory T cells was also significantly increased in the COC group (6.3, 2.8–15.5) versus 0 (0–1.8; p < 0.001). Conclusions The effects of COC, containing EE 0.30 mg with desogestrel 0.15 mg, on the immune system was demonstrated by a significant decrease in the number of macrophages and an increase in natural killer and regulatory T cells.


Sign in / Sign up

Export Citation Format

Share Document